NCT02937207 is a Phase 2 clinical trial of Ke Chuan Liu Wei Mixture in Bronchial Asthma, sponsored by Shanghai University of Traditional Chinese Medicine.

Who is sponsoring NCT02937207?

NCT02937207 is sponsored by Shanghai University of Traditional Chinese Medicine.

What drugs are being tested in NCT02937207?

Interventions in NCT02937207: Ke Chuan Liu Wei Mixture, Chuan Xiong Ping Chuan Mixture, Xie Wu Capsule, Dan Ma Jia Tablet, Zhi Chuan Capsule, Bu Shen Na Qi Granule, Ke Chuan Liu Wei Mixture placebo, Chuan Xiong Ping Chuan Mixture placebo, Xie Wu Capsule placebo, Dan Ma Jia Tablet placebo, Zhi Chuan Capsule placebo, Bu Shen Na Qi Granule placebo.

What condition does NCT02937207 study?

NCT02937207 studies Bronchial Asthma.

Is NCT02937207 still recruiting?

NCT02937207 is currently status unknown. Last updated 24 February 2020.

Last reviewed 2020-02-24 · How we verify

NCT02937207

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine

Status unknown Phase 2 Last updated 24 February 2020

What this trial tests

Phase 2 trial testing Ke Chuan Liu Wei Mixture in Bronchial Asthma in 288 participants. Status unknown.

Timeline

30 July 2017

Primary endpoint
1 December 2020

1 December 2021

Quick facts

Lead sponsor	Shanghai University of Traditional Chinese Medicine
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	288
Start date	30 July 2017
Primary completion	1 December 2020
Estimated completion	1 December 2021
Sites	5 locations across China

Drugs / interventions tested

Ke Chuan Liu Wei Mixture — full drug profile →
Chuan Xiong Ping Chuan Mixture — full drug profile →
Xie Wu Capsule — full drug profile →
Dan Ma Jia Tablet — full drug profile →
Zhi Chuan Capsule
Bu Shen Na Qi Granule — full drug profile →
Ke Chuan Liu Wei Mixture placebo
Chuan Xiong Ping Chuan Mixture placebo
Xie Wu Capsule placebo
Dan Ma Jia Tablet placebo
Zhi Chuan Capsule placebo
Bu Shen Na Qi Granule placebo

Conditions studied

Bronchial Asthma — all drugs for Bronchial Asthma →

Sponsor

Shanghai University of Traditional Chinese Medicine

Who can join

Adults 18 to 45, any sex, with Bronchial Asthma. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Asthma control rate
Time frame: up to 12 months
Asthma control rate will be measured during study of asthma at exacerbation stage within 44 days and symptom-free months will be measured on remission period within 12 months

Sponsor's own description

The purpose of this study is to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of asthma, and to promote the application in community hospitals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bronchial Asthma

Currently open trials in the same condition.

NCT07183657 — Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and · NA · recruiting
NCT07054034 — Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects · Phase 2 · active not recruiting
NCT07060079 — The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease · recruiting
NCT06721247 — Oral Intake of Mg in Controlled Asthmatic Patients · Phase 2, PHASE3 · active not recruiting
NCT06852911 — FeNO Detection in Asthma Diagnosis: A New Technology Approach · NA · recruiting

Other Shanghai University of Traditional Chinese Medicine trials

Trials by the same sponsor.

NCT07331740 — Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer P · NA · not yet recruiting
NCT07069049 — Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local Anesthesia · NA · not yet recruiting
NCT07245342 — Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy · NA · not yet recruiting
NCT06921512 — TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms · NA · recruiting
NCT06690606 — EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02937207 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai University of Traditional Chinese Medicine
Last refreshed: 24 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02937207.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing